Swiss clinical research organisation PSI CRO has appointed Andrea Cracraft as its new director of clinical operations for North America.
Cracraft joins the Zug-headquartered company after spending eight years at PPD and in total brings to PSI more than 15 years of clinical research experience.
During that time she has run global projects in therapeutic areas that have included oncology, respiratory, CNS and cardiovascular.
She said: “This is a remarkable opportunity and I am delighted to have joined PSI. PSI is known for keeping and developing talent. I am happy to have a chance to contribute to the growth of clinical operations in North America and to build upon the company’s excellent reputation for delivering clinical trials on schedule and on budget for our clients.”